Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 2

Serum total hCG and free ß-HCG in preeclampsia and eclampsia

Preeklampsi ve eklampside serum total HCG ve serbest ß-HCG'nin yeri

Pages
192–197
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased serum total hCG and free ß-hCG levels might indicate the severity of the disease but they could not be used as early predictive markers or determinant of preeclampsia in general sense.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate whether the serum total hCG and free ß-hCG levels are related to pathogenesis and severity of the diseases in preeclamptic patients.
📊
Key Findings & Data:Material and methods: The study group comprised of 75 pregnant women with preeclampsia and a total of 75 healthy pregnant controls who attended the Ondokuz Mayıs University Obstetrics and Gynecology Department.
💡
Conclusion & Impact:Increased serum total hCG and free ß-hCG levels might indicate the severity of the disease but they could not be used as early predictive markers or determinant of preeclampsia in general sense.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Korionik gonadotropin · beta subunit · insan

Abstract

Objective: The aim of this study is to investigate whether the serum total hCG and free ß-hCG levels are related to pathogenesis and severity of the diseases in preeclamptic patients. Material and methods: The study group comprised of 75 pregnant women with preeclampsia and a total of 75 healthy pregnant controls who attended the Ondokuz Mayıs University Obstetrics and Gynecology Department. Serum total hCG and serum free ß-hCG levels were determined by the ELİSA method. Statistical analyses were done using Student T, x2 and Mann Whitney U tests. Results: There were no significant differences in serum levels of total hCGand free ß-hCG between patients with mild preeclampsia and those of their macthed controls (p>0.05). Patients with preeclampsia and eclampsia had significantly different serum levels of total hCG when compared to their control group (p<0.05). Patients with severe preeclampsia and eclampsia had significantly different serum levels of free ß-hCG when compared to their control groups (p<0.05). There were no significant differences in serum free ß-hCG levels among mild, severe preeclamptic and eclamptic groups (p>0.05). Conclusion: As a conclusion serum total hCG and free ß-hCG levels could be supportive markers in the diagnosis of severe preeclampsia and eclampsia. Increased serum total hCG and free ß-hCG levels might indicate the severity of the disease but they could not be used as early predictive markers or determinant of preeclampsia in general sense.

Özet

Amaç: Bu çalışmanın amacı; pre-eklampsili olgularda serum total hCG ve serbest ß-hCG seviyelerinin hastalığın patogenezi ve şiddeti ile ilişkisi olup olmadığını araştırmaktır. Gereç ve Yöntem: 75 pre-eklampsili ve gebelik haftaları hasta grubuna uygun toplam 75 sağlıklı gebeden oluşan kontrol grubu olgularda total hCG ve serbest ß-hCG değerleri karşılaştırıldı. Alınan serum örnekleri ELİSA yöntemi ile çalışıldı. Elde edilen veriler istatistiksel olarak Student T, x2 ve Mann Whitney U testleri ile değerlendirildi. Bulgular: Hafif preeklampsi ile kontrol grubu arasında total hCG ve serbest ß-hCG düzeyleri yönünden istatistiksel olarak anlamlı fark bulunmadı (p>0.05). Ancak şiddetli preeklampsi ve eklampsi ile kontrol grupları arasında fark anlamlı olarak saptandı (p 0.05), şiddetli preeklampsi ile eklampsi arasındaki fark anlamlı olarak saptandı (P 0.05). Sonuç: Serum total hCG ve serbest ß-hCG düzeyleri, kontrollere göre hafif preeklampsi hastalarında fark göstermemektedir. Ancak, şiddetli preeklampsi ve eklampsi grubunda, kontrol grubu hastalara göre istatistiksel olarak anlamlı düzeyde yüksektir. Bütün bu bulgular serum total hCG ve serbest ß-hCG düzeylerinin preeklampsi gelişiminin öngörülmesinde bir belirteç olarak fazla bir anlam ifade etmediğini ancak hastalığın şiddetini destekleyici belirteçlerden biri olabileceğini göstermektedir.

🔖

Cite This Article

BEDİR, A., MALATYALIOĞLU, E., ÇETİNKAYA, M. B., KÖKÇÜ, A., ALPER, T. (2005). Serum total hCG and free ß-HCG in preeclampsia and eclampsia. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 2, 192–197. https://ajindex.com/articles/278356

References (14)

  1. Fox H, Kharkongor FN. Immunofluorescent localization of ıorionic gonadotropin in the placenta and in tissue cultures of jman trophoblast. J Pathol 1970
  2. Vaitukaitis Jl_, Ebersole ER. Evidence for altered synthesis: human chorionic gonadotropin in gestational trophoblastic mor. J Clin Endocrinol Metab 1976
  3. Hoshina M, Ashitaka Y, Tojo S. Immunohistochemical iteraction on antisera to hCG and its subunits with chorionic ssue of early gestation. Endocrinol Jpn 1979
  4. 84 4. Curry SL, Hammond CB, Tyrey L, Creasman WT.Parker RT. lydatidiform mole: diagnosis, management, and long-term )llow-up of 347 patients. Obstet Gynecol 1975
  5. 8 5. Long PA, Oat JN. Preeclampsia in twin pregnancy: severity nd pathogenesis. Aust N Z J Obstet Gynaecol 1987
  6. 5 6. Sibai BM. Hypertension in pregnancy. In: Gabbe SG, Niebly R, Simpson JL (eds.). Obstetrics Normal And Problem 'regnancies (4th ed). Vol 28. New York, Churchill Livingstone, 1001:945-1004. 7. Cole LA: Immunoassay of human chorionic gonadotropin, its ree subunits, and metabolites. Clinical Chemistry 1997
  7. L3:2233-43 sasa 8. Lee IS, Chung DYK, Cole LA et al: Elevated serum nicked ind urinary Beta-core fragment hCG in preeclamptic Dregnancies. Obstet Gynecol 1997
  8. Hsu CD, Chan DW, İriye B, Jonhnson TRB, Hong SF, Repke JT. Elevated serum human chorionic gonadotropin as evidence Df secretory response in severe preeclampsia. Am J Obstet Gynecol 1994
  9. 8 10. Roberts JM, Taylor RN, Musci TJ. Preeclampsia: an endotelial cell disorder. Am J Obstet Gynecol 1989
  10. Robertson WB, Khong TY, Brosens I, De Wolf, Sheppard BL, Bonnar J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986
  11. Smith GVS, Smith OW. The anterior pituitary-tike hormone in late pregnancy toxemia: a summary of results since 1982. Amj Obstet Gynecol 1939
  12. Brosens IA. Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynaecol 1977
  13. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993
  14. 8 15.Dekker GA. Predition and prevention of pregnancy induced hypertension and disorders: A Clinical and Pathophysiologic Study (Thesis) Rotterdam: Erasmus University 1989:18-21. 16.Weiner CP, Kwaan HC, Xu C, Poul M, Burmeister L, Houck W. Antithromb